News

JD Wetherspoon today said warm weather boosted trading after reporting a 5.1% rise in like-for-like sales for the 12 weeks to Sunday. The group, which operates 794 pubs, added that profits are in line ...
The enterprise suite introduces four key AI agents – finance, payments, accounting and project management – each designed to ...
Find insight on Bruker, Sartorius, Sarepta and more in the latest Market Talks covering Health Care.
GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...
This summary highlights significant events in the health sector, including Johnson & Johnson's profit boost from Darzalex, safety concerns for GSK's cancer drug, refugee malnutrition in Gaza, KKR's ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common ... which is more than double the S&P 500's performance over the same time frame. However, ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investing.com -- Berenberg has lowered its rating on GSK plc (LON: GSK) to Hold from Buy, a move driven by the stock’s strong year-to-date (YTD) performance and an expected pause in investor ...
Investing.com -- Berenberg has lowered its rating on GSK plc (LON:GSK) to Hold from Buy, a move driven by the stock’s strong year-to-date (YTD) performance and an expected pause in investor ...
GSK Turnover, Net Profit Expected to Rise; Weaker Vaccine Performance in Focus -- Earnings Preview Published: April 28, 2025, 9:23 a.m. ET Share Resize ...
GSK lifts long-term sales targets on new drug pipeline It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024.
Graham Parry, an analyst from Bank of America Securities, maintained the Sell rating on GlaxoSmithKline (GSK – Research Report). The associated price target was lowered to p1,415.00.